IMI Members
Factsheets for IMI projects
The Innovative Medicines Initiative (IMI) now has 23 projects that are up and running as a result of the successful launches of its 1st and 2nd Calls.
All Projects
- BTCure
Be The Cure
- DDMoRe
Drug Disease Model Resources
- EHR4CR
Electronic Health Records Systems for Clinical Research
- EMTRAIN
European Medicines Research Training Network
- eTOX
Integrating bioinformatics and chemoinformatics approaches for the development of Expert systems allowing the in silico prediction of toxicities
- Eu2P
European programme in Pharmacovigilance and Pharmacoepidemiology
- EUROPAIN
Understanding chronic pain and improving its treatment
- IMIDIA
Improving beta-cell function and identification of diagnostic biomarkers For treatment monitoring in diabetes
- MARCAR
Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis
- NEWMEDS
Novel methods leading to new medications in depression and schizophrenia
- Onco Track
Methods for systematic next generation oncology biomarker development
- Open PHACTS
The Open Pharmacological Concepts Triple Store
- Pharma-Cog
Prediction of cognitive properties of new drug candidates For neurodegenerative diseases in early clinical development
- Pharmatrain
Pharmaceutical Medicine Training Programme
- Predect
New models for preclinical evaluation of drug efficacy in common solid tumours
- PRO-active
Physical Activity as a Crucial Patient Reported Outcome in COPD
- PROTECT
Pharmacoepidemiiological research on outcomes Of therapeutics by a european consortium
- Quic-Concept
Quantative imaging in cancer:connecting cellular process with therapy
- RAPP-ID
Development of rapid point-of-care test platforms for infectious diseases
- SAFE-T
Safer and Faster Evidence-based Translation
- SafeSciMET
European Modular Education and Training Programme in Safety Sciences for Medicines
- SUMMIT
Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools
- U-BIOPRED
Unbiased biomarkers for the prediction of respiratory disease outcomes
Innovative Medicines Initiative 2010